VIDEO: Gene therapy exploration in AMD

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Being explored for dry or nonexudative macular degeneration in a variety of different stages, both in the stage of intermediate AMD but also for advanced AMD and the prevention of progression in those patients. Actually it's the ideal way of delivering it, I think, for those patients in particular because when you look at these patients over time the progression rates are quite significant. 25 to 30% of patients can lose a significant amount of area of that central part of their vision in a rapid fashion over even a year or two years' time. So really gene therapy could be a one-and-done therapy, especially for this sort of condition. Now it's not restorative right now in the current studies that are being done but it is preventing the progression of those patients. And there's a couple different companies now investigating those pathways potentially.